Impact of reimbursement restriction on drug market sales under the National Health Insurance in Japan-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Impact of reimbursement restriction on drug market sales under the National Health Insurance in Japan

Published:2022-02-09 Issue:1 Volume:25 Page:206-211
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Mamiya Hiroaki¹^ORCID,Igarashi Ataru¹²^ORCID

Affiliation:

1. Department of Health Economics and Outcomes Research, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan

2. Unit of Public Health and Preventive Medicine, School of Medicine, Yokohama City University, Yokohama, Japan

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2022.2032096

Reference23 articles.

1. Health Care Spending in the United States and Other High-Income Countries

2. The High Cost of Prescription Drugs in the United States

3. Value-Based Pricing for Drugs

4. Drug Reimbursement Regulation in 6 Peer Countries

5. How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Pilot Study on the Drug Price Revision Strategy in Japan: A Comparison Among Fiscal Years 2018, 2020, and 2022;Hospital Pharmacy;2024-08-06

2. Increasing orphan drug loss in Japan: Trends and R&D strategy for rare diseases;Drug Discovery Today;2023-10

3. Trends in anti-HER2 drugs consumption and influencing factors;Frontiers in Public Health;2022-09-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP